Cartesian Therapeutics(RNAC) - 2020 Q2 - Earnings Call Transcript

Selecta Biosciences, Inc. (SELB) Q2 2020 Results Conference Call August 6, 2020 8:30 AM ET Company Participants Brad Dahms - CFO Carsten Brunn - President and CEO Dr. Peter G. Traber - Chief Medical Officer Takashi Kishimoto - Chief Scientific Officer Conference Call Participants Eliana Merle - Cantor Fitzgerald John Newman - Canaccord Raju Prasad - William Blair Ben Porter - Stifel Dan Clark - Mizuho Boobalan Pachaiyappan - H.C. Wainwright Operator Good morning, and welcome to the Selecta Biosciences Secon ...